Indonesia-based digital health services company Halodoc has raised USD65 million in a Series B funding round led by UOB Venture Management, the direct equities arm of Singapore-based financial services group United Overseas Bank. Other investors in the Series B include private equity fund manager Korea Investment Partners, China-based health care group WuXi Apptec, and Singtel Innov8, the venture capital arm of Singapore-based telecommunications company Singtel. Halodoc provides medical consultation, lab test ordering, and medication delivery services through its website and mobile application. The company plans to use part of the new funding to develop an online-to-offline health care system for hospitals and insurance companies.